Since the enactment of the Biologics Price Competition and Innovation Act (BPCIA), the Federal Drug Administration (FDA) has approved more than 20 biosimilar products, and, as the market has grown, litigation activity concerning biosimilars has increased rapidly. Signed into law as part of the Affordable Care Act on March 23, 2010, the BPCIA is codified …
Filtered by tag:
FDA
States take the lead on e-cigarette legislation, according to WestlawNext
On the heels of today’s Food and Drug Administration (FDA) proposed rules for electronic cigarettes, also known as e-cigarettes, 46 states have already proposed or enacted legislation related to e-cigarettes, according to data found on WestlawNext, the leading online legal research service. Of those states, at least 20 have proposed or enacted legislation that includes …
- April 24, 2014
- Alex Cook
Trademark report reveals new challenges and opportunities for pharmaceutical brands
Strict governmental standards for brand names have forced the global pharmaceutical industry to adapt by rapidly increasing the number of trademarks it files for every new drug, according to a new report published by Thomson CompuMark. These additional efforts to secure a trademark are an attempt to combat the increasing rate of rejection from the Food …
- July 12, 2011
- Susan Martin
Examining the changing global pharmaceutical landscape from a trademark perspective
The creation and clearance of pharmaceutical trademarks continues to be one of the most challenging areas of trademark law. Thomson CompuMark’s free upcoming webinar offers the opportunity to learn about the continuing evolution of the international regulatory environments and the current issues that affect pharmaceutical brand owners globally. Hear what pharmaceutical companies around the world …
- March 23, 2011
- Susan Martin